Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors
(Q46630294)
scientific article published in August 2005
scientific article published in August 2005
Language:
other details
description | scientific article published in August 2005 |
External Links
(P356) |
10.1158/1078-0432.CCR-04-2658
|
(P698) |
16061863
|